Estrella Immunopharma
ESLA
ESLA
23 hedge funds and large institutions have $34.5M invested in Estrella Immunopharma in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
5
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
PCM
1
Pinz Capital Management
New York
|
$0 |
2 |
SSA
2
Schonfeld Strategic Advisors
New York
|
$0 |
3 |
3
Goldman Sachs
New York
|
$971K |